These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28594891)

  • 21. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.
    Teshome S; Desai S; Kim JH; Belay D; Mogasale V
    Hum Vaccin Immunother; 2018; 14(10):2427-2433. PubMed ID: 29648523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using Mobile Health (mHealth) and geospatial mapping technology in a mass campaign for reactive oral cholera vaccination in rural Haiti.
    Teng JE; Thomson DR; Lascher JS; Raymond M; Ivers LC
    PLoS Negl Trop Dis; 2014; 8(7):e3050. PubMed ID: 25078790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia.
    Park SE; Gedefaw A; Hailu D; Jeon Y; Mogeni OD; Jang GH; Mukasa D; Mraidi R; Kim DR; Getahun T; Mesfin Getachew E; Yeshitela B; Ayele Abebe S; Hussen M; Worku Demlie Y; Teferi M
    Clin Infect Dis; 2024 Jul; 79(Supplement_1):S33-S42. PubMed ID: 38996035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau.
    Azman AS; Luquero FJ; Rodrigues A; Palma PP; Grais RF; Banga CN; Grenfell BT; Lessler J
    PLoS Negl Trop Dis; 2012; 6(11):e1901. PubMed ID: 23145204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014.
    Azman AS; Rumunu J; Abubakar A; West H; Ciglenecki I; Helderman T; Wamala JF; Vázquez Ode L; Perea W; Sack DA; Legros D; Martin S; Lessler J; Luquero FJ
    Emerg Infect Dis; 2016 Jun; 22(6):1067-70. PubMed ID: 27192187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.
    Edosa M; Jeon Y; Gedefaw A; Hailu D; Mesfin Getachew E; Mogeni OD; Jang GH; Mukasa D; Yeshitela B; Getahun T; Lynch J; Bouhenia M; Worku Demlie Y; Hussen M; Wossen M; Teferi M; Park SE
    Clin Infect Dis; 2024 Jul; 79(Supplement_1):S20-S32. PubMed ID: 38996040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study.
    Malembaka EB; Bugeme PM; Hutchins C; Xu H; Hulse JD; Demby MN; Gallandat K; Saidi JM; Rumedeka BB; Itongwa M; Tshiwedi-Tsilabia E; Kitoga F; Bodisa-Matamu T; Kavunga-Membo H; Bengehya J; Kulondwa JC; Debes AK; Taty N; Lee EC; Lunguya O; Lessler J; Leung DT; Cumming O; Okitayemba PW; Mukadi-Bamuleka D; Knee J; Azman AS
    Lancet Infect Dis; 2024 May; 24(5):514-522. PubMed ID: 38246191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholera vaccination in urban Haiti.
    Rouzier V; Severe K; Juste MAJ; Peck M; Perodin C; Severe P; Deschamps MM; Verdier RI; Prince S; Francois J; Cadet JR; Guillaume FD; Wright PF; Pape JW
    Am J Trop Med Hyg; 2013 Oct; 89(4):671-681. PubMed ID: 24106194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016.
    Sauvageot D; Saussier C; Gobeze A; Chipeta S; Mhango I; Kawalazira G; Mengel MA; Legros D; Cavailler P; M'bang'ombe M
    Vaccine; 2017 Sep; 35(38):5194-5200. PubMed ID: 28803712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
    Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
    Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.
    Azman AS; Parker LA; Rumunu J; Tadesse F; Grandesso F; Deng LL; Lino RL; Bior BK; Lasuba M; Page AL; Ontweka L; Llosa AE; Cohuet S; Pezzoli L; Sodjinou DV; Abubakar A; Debes AK; Mpairwe AM; Wamala JF; Jamet C; Lessler J; Sack DA; Quilici ML; Ciglenecki I; Luquero FJ
    Lancet Glob Health; 2016 Nov; 4(11):e856-e863. PubMed ID: 27765293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan.
    Iyer AS; Bouhenia M; Rumunu J; Abubakar A; Gruninger RJ; Pita J; Lino RL; Deng LL; Wamala JF; Ryan ET; Martin S; Legros D; Lessler J; Sack DA; Luquero FJ; Leung DT; Azman AS
    Sci Rep; 2016 Oct; 6():35742. PubMed ID: 27775046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.
    Phares CR; Date K; Travers P; Déglise C; Wongjindanon N; Ortega L; Bhuket PR
    Vaccine; 2016 Jan; 34(1):128-33. PubMed ID: 26549363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda.
    Bwire G; Roskosky M; Ballard A; Brooks WA; Okello A; Rafael F; Ampeire I; Orach CG; Sack DA
    BMJ Open; 2020 Dec; 10(12):e038464. PubMed ID: 33303438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Ray A; Sarkar K; Haldar P; Ghosh R
    Vaccine; 2020 Feb; 38 Suppl 1():A184-A193. PubMed ID: 31377080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
    Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
    Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.
    Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F
    Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
    Franke MF; Ternier R; Jerome JG; Matias WR; Harris JB; Ivers LC
    Lancet Glob Health; 2018 Sep; 6(9):e1028-e1035. PubMed ID: 30103980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and future cholera vaccines.
    Shaikh H; Lynch J; Kim J; Excler JL
    Vaccine; 2020 Feb; 38 Suppl 1():A118-A126. PubMed ID: 31879125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of oral cholera vaccine in Haiti: a rural demonstration project.
    Ivers LC; Teng JE; Lascher J; Raymond M; Weigel J; Victor N; Jerome JG; Hilaire IJ; Almazor CP; Ternier R; Cadet J; Francois J; Guillaume FD; Farmer PE
    Am J Trop Med Hyg; 2013 Oct; 89(4):617-624. PubMed ID: 24106187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.